Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19

BACKGROUND AND PURPOSE: Neurological manifestations in coronavirus disease (COVID)‐2019 may adversely affect clinical outcomes. Severe COVID‐19 and uremia are risk factors for neurological complications. However, the lack of insight into their pathogenesis, particularly with respect to the role of t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Neurol
Main Authors: Perrin, P., Collongues, N., Baloglu, S., Bedo, D., Bassand, X., Lavaux, T., Gautier‐Vargas, G., Keller, N., Kremer, S., Fafi‐Kremer, S., Moulin, B., Benotmane, I., Caillard, S.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Infectious Diseases
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7461405/
https://ncbi.nlm.nih.gov/pubmed/32853434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.14491
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares